Hoyoung Shin
About Hoyoung Shin
Hoyoung Shin is the GRS International Strategy Lead, Associate Director at Bristol-Myers Squibb in New Jersey, USA, with extensive experience in regulatory affairs and strategy.
Company
Hoyoung Shin currently works at Bristol-Myers Squibb in New Jersey, USA. His role is integral to the company's regulatory strategy on an international level, ensuring that development plans are aligned with global and local regulatory requirements. Bristol-Myers Squibb is a leading global biopharmaceutical company focused on discovering, developing, and delivering innovative medicines to patients globally.
Title
Hoyoung Shin holds the position of GRS International Strategy Lead, Associate Director at Bristol-Myers Squibb. His role involves providing regulatory input to development strategies and advising global teams on local regulatory requirements, ensuring timely and compliant product registrations.
Previous Roles at Bristol-Myers Squibb
Before his current role, Hoyoung Shin was the Korea Regulatory Strategy Lead at Bristol-Myers Squibb from 2011 to 2018. Based in Gangnam-gu, Seoul, Korea, he contributed significantly to regulatory strategies and compliance requirements specific to the Korean market over a seven-year period.
Previous Experience in Pharmaceutical Industry
Hoyoung Shin has a diverse background in the pharmaceutical industry. From 2007 to 2011, he worked as an RA Manager at Korea Otsuka Pharmaceutical Co., Ltd., overseeing regulatory affairs. Prior to that, he served as a Senior Scientist at ILYANG for five years, contributing to the company's scientific initiatives in Yongin, Gyeonggi-do, Korea.
Education and Expertise
Hoyoung Shin studied at Kyung Hee University, where he earned both an MSc and BSc in Microbiology, Immunology, and Pharmacy. His education provided a foundation in the scientific and regulatory aspects of the pharmaceutical industry, which he has applied in various roles throughout his career.